The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs
Abstract
Persistent infection with hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. All treatments known so far rely on the antiviral activity of interferon alfa (IFN-α) that is given alone or in combination with ribavirin. Unfortunately, only a fraction of the patients clear the virus during therapy and for those who do not respond there is currently no alternative treatment. Selectable subgenomic HCV RNAs (replicons) have been recently used to investigate the effect of IFN-α on HCV replication. However, it has not yet been analyzed whether other cytokines also play a role in the innate immune response against HCV. Here we show that IFN-γ inhibits protein synthesis and RNA replication of subgenomic and genomic HCV replicons. We further show that the inhibitory action of IFN-γ does not rely on the production of nitric oxide or the depletion of tryptophan. In conclusion, our results suggest that cytotoxic T cells and natural killer cells may contribute to HCV clearance not only by cell killing but also by producing IFN-γ, thereby enhancing the intracellular inhibition of viral replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Self-citationCella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate
Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D., & Wishnok, J. S. (1988) · Biochemistry · doi:10.1021/bi00424a003 · Cited by 1,600
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G. M., Lee, S. S., Balart, L., Reindollar, R., Reddy, R. K., Wright, T. L., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432302 · Cited by 874
Analysis of a Successful Immune Response against Hepatitis C Virus
Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., & Walker, C. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80044-8 · Cited by 814
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
Gerlach, J. T., Diepolder, H. M., Jung, M., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R., Schirren, C. A., Santantonio, T., & Pape, G. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70353-7 · Cited by 714
Replication of hepatitis C virus
Bartenschlager, R., & Lohmann, V. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1631 · Cited by 611
Self-citationThe Double-Stranded RNA-Dependent Protein Kinase PKR: Structure and Function
CLEMENS, M. J., & ELIA, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.503 · Cited by 605
Akaike, T., Noguchi, Y., Ijiri, S., Setoguchi, K., Suga, M., Zheng, Y. M., Dietzschold, B., & Maeda, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2448 · Cited by 496
L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase
Moore, W. M., Webber, R. K., Jerome, G. M., Tjoeng, F. S., Misko, T. P., & Currie, M. G. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00049a007 · Cited by 456
Effect of Alpha Interferon on the Hepatitis C Virus Replicon
Guo, J.-T., Bichko, V. V., & Seeger, C. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8516-8523.2001 · Cited by 443
Eyster, M., Fried, M., Di Bisceglie, A., & Goedert, J. (1994) · Blood · doi:10.1182/blood.v84.4.1020.1020 · Cited by 363
Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs
Pietschmann, T., Lohmann, V., Rutter, G., Kurpanek, K., & Bartenschlager, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1252-1264.2001 · Cited by 356
Self-citationDifferential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
Chang, K.-M., Thimme, R., Melpolder, J. J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J. G., Alter, H. J., & Chisari, F. V. (2001) · Hepatology · doi:10.1053/jhep.2001.21162 · Cited by 336
Cady, S. G., & Sono, M. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90142-6 · Cited by 285
Mx proteins: mediators of innate resistance to RNA viruses: -EN- -FR- -ES-
HALLER, O., FRESE, M., & KOCHS, G. (1998) · Revue Scientifique et Technique de l'OIE · doi:10.20506/rst.17.1.1084 · Cited by 284
Self-citationWölk, B., Sansonno, D., Kräusslich, H.-G., Dammacco, F., Rice, C. M., Blum, H. E., & Moradpour, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2293-2304.2000 · Cited by 282
Hepatitis C--global prevalence (update).
(1999) · PubMed · Cited by 270
An Antiviral Mechanism of Nitric Oxide
Saura, M., Zaragoza, C., McMillan, A., Quick, R. A., Hohenadl, C., Lowenstein, J. M., & Lowenstein, C. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80003-5 · Cited by 245
Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
Frese, M., Pietschmann, T., Moradpour, D., Haller, O., & Bartenschlager, R. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-4-723 · Cited by 211
Self-citationHow Hepatitis C Virus Counteracts the Interferon Response: The Jury Is Still out on NS5A
Tan, S.-L., & Katze, M. G. (2001) · Virology · doi:10.1006/viro.2001.0885 · Cited by 204
Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J., & Michelson, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.957 · Cited by 194
Karupiah, G., Chen, J.-H., Mahalingam, S., Nathan, C. F., & MacMicking, J. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1541 · Cited by 183
Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J. L., & Michelson, S. (1999) · PubMed · Cited by 180
Daghigh, F., Fukuto, J. M., & Ash, D. E. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1909 · Cited by 170
Boucher, J. L., Custot, J., Vadon, S., Delaforge, M., Lepoivre, M., Tenu, J. P., Yapo, A., & Mansuy, D. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2371 · Cited by 170
The natural history of chronic hepatitis C in haemophiliacs
Makris, M., Preston, F. E., Rosendaal, F. R., Underwood, J. C. E., Rice, K. M., & Triger, D. R. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.02343.x · Cited by 170
Mikovits, J. A., Young, H. A., Vertino, P., Issa, J.-P. J., Pitha, P. M., Turcoski-Corrales, S., Taub, D. D., Petrow, C. L., Baylin, S. B., & Ruscetti, F. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5166 · Cited by 160
Majano, P. L., García‐Monzón, C., López‐Cabrera, M., Lara‐Pezzi, E., Fernández‐Ruiz, E., García-Iglesias, C., Borque, M. J., & Moreno‐Otero, R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci774 · Cited by 151
Cytokine-Mediated Control of Viral Infections
Guidotti, L. G., & Chisari, F. V. (2000) · Virology · doi:10.1006/viro.2000.0442 · Cited by 151
Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects
Carlin, J. M., Ozaki, Y., Byrne, G. I., Brown, R. R., & Borden, E. C. (1989) · Cellular and Molecular Life Sciences · doi:10.1007/bf01990503 · Cited by 140
Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice
Guidotti, L. G., McClary, H., Loudis, J. M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1247 · Cited by 120
Tambur, A. R., Ortegel, J. W., Ben‐Ari, Z., Shabtai, E., Klein, T., Michowiz, R., Tur-Kaspa, R., & Mor, E. (2001) · Transplantation · doi:10.1097/00007890-200105270-00020 · Cited by 78
Mihm, S., Fayyazi, A., & Ramadori, G. P. (1997) · Hepatology · doi:10.1002/hep.510260228 · Cited by 74
Self-citationInterferon-induced gene expression and signaling in human hepatoma cell lines
Melén, K., Keskinen, P., Lehtonen, A., & Julkunen, I. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80308-6 · Cited by 62
Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide
Shami, P., Sauls, D., & Weinberg, J. (1998) · Leukemia · doi:10.1038/sj.leu.2401131 · Cited by 57
Schweyer, S., Mihm, S., Radzun, H., Hartmann, H., & Fayyazi, A. (2000) · Gut · doi:10.1136/gut.46.2.255 · Cited by 54
Self-citationRegulation of β2-microglobulin expression in different human cell lines by proinflammatory cytokines
Vraetz, T., Ittel, T. H., van Mackelenbergh, M. G. H., Heinrich, P. C., Sieberth, H. G., & Graeve, L. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.9.2137 · Cited by 45
Natural History and Disease Manifestations of Hepatitis C Infection
Theodore, D., & Fried, M. W. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_3 · Cited by 34
Current and evolving therapies for hepatitis C
Moradpour, D., & Blum, H. E. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199911000-00002 · Cited by 34
(1982) · PubMed
Cited by
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
Feld, J. J., & Hoofnagle, J. H. (2005) · Nature · doi:10.1038/nature04082 · Cited by 992
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Adaptive immune responses in acute and chronic hepatitis C virus infection
Bowen, D. G., & Walker, C. M. (2005) · Nature · doi:10.1038/nature04079 · Cited by 756
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
Shoukry, N. H., Grakoui, A., Houghton, M., Chien, D. Y., Ghrayeb, J., Reimann, K. A., & Walker, C. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030239 · Cited by 656
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608299 · Cited by 639
Metadata
- Authors
- Frese, M., Schwärzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O., & Bartenschlager, R.
- Venue
- Hepatology
- Published
- 2002-03
- Volume
- 35
- Issue
- 3
- Pages
- 694-703
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2045733748
- Cited by
- 314
- References
- 50
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.